These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 16644397)

  • 1. [Current and future biochemical markers for Gaucher disease].
    Froissart R
    Rev Med Interne; 2006 Mar; 27 Suppl 1():S22-5. PubMed ID: 16644397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Current development and usefulness of biomarkers for Gaucher disease follow up].
    Maire I; Guffon N; Froissart R
    Rev Med Interne; 2007 Oct; 28 Suppl 2():S187-92. PubMed ID: 18228687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma chitotriosidase activity versus CCL18 level for assessing type I Gaucher disease severity: protocol for a systematic review with meta-analysis of individual participant data.
    Raskovalova T; Deegan PB; Yang R; Pavlova E; Stirnemann J; Labarère J; Zimran A; Mistry PK; Berger M
    Syst Rev; 2017 Apr; 6(1):87. PubMed ID: 28427477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CCL18 as an alternative marker in Gaucher and Niemann-Pick disease with chitotriosidase deficiency.
    Chang KL; Hwu WL; Yeh HY; Lee NC; Chien YH
    Blood Cells Mol Dis; 2010 Jan; 44(1):38-40. PubMed ID: 19819171
    [No Abstract]   [Full Text] [Related]  

  • 5. Marked elevation of the chemokine CCL18/PARC in Gaucher disease: a novel surrogate marker for assessing therapeutic intervention.
    Boot RG; Verhoek M; de Fost M; Hollak CE; Maas M; Bleijlevens B; van Breemen MJ; van Meurs M; Boven LA; Laman JD; Moran MT; Cox TM; Aerts JM
    Blood; 2004 Jan; 103(1):33-9. PubMed ID: 12969956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diagnosis, biomarkers and biochemical alterations in Gaucher's disease].
    Gort L; Coll MJ
    Med Clin (Barc); 2011 Sep; 137 Suppl 1():12-6. PubMed ID: 22230120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma chitotriosidase and CCL18 as surrogate markers for granulomatous macrophages in sarcoidosis.
    Boot RG; Hollak CE; Verhoek M; Alberts C; Jonkers RE; Aerts JM
    Clin Chim Acta; 2010 Jan; 411(1-2):31-6. PubMed ID: 19808030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of three biochemical markers in the monitoring of Gaucher disease.
    Vellodi A; Foo Y; Cole TJ
    J Inherit Metab Dis; 2005; 28(4):585-92. PubMed ID: 15902562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CCL18: a urinary marker of Gaucher cell burden in Gaucher patients.
    Boot RG; Verhoek M; Langeveld M; Renkema GH; Hollak CE; Weening JJ; Donker-Koopman WE; Groener JE; Aerts JM
    J Inherit Metab Dis; 2006 Aug; 29(4):564-71. PubMed ID: 16736095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and use of biomarkers in Gaucher disease and other lysosomal storage diseases.
    Aerts JM; Hollak CE; van Breemen M; Maas M; Groener JE; Boot RG
    Acta Paediatr Suppl; 2005 Mar; 94(447):43-6; discussion 37-8. PubMed ID: 15895711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationships between serum markers of monocyte/macrophage activation in type 1 Gaucher's disease.
    Casal JA; Lacerda L; Pérez LF; Pinto RA; Clara Sá Miranda M; Carlos Tutor J
    Clin Chem Lab Med; 2002 Jan; 40(1):52-5. PubMed ID: 11924537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mass spectrometric quantification of glucosylsphingosine in plasma and urine of type 1 Gaucher patients using an isotope standard.
    Mirzaian M; Wisse P; Ferraz MJ; Gold H; Donker-Koopman WE; Verhoek M; Overkleeft HS; Boot RG; Kramer G; Dekker N; Aerts JM
    Blood Cells Mol Dis; 2015 Apr; 54(4):307-14. PubMed ID: 25842368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biomarkers in Serbian patients with Gaucher disease.
    Sumarac Z; Suvajdžić N; Ignjatović S; Majkić-Singh N; Janić D; Petakov M; Dorđević M; Mitrović M; Dajak M; Golubović M; Rodić P
    Clin Biochem; 2011 Aug; 44(12):950-4. PubMed ID: 21640089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ten years' experience of enzyme infusion therapy of Norrbottnian (type 3) Gaucher disease.
    Erikson A; Forsberg H; Nilsson M; Aström M; Månsson JE
    Acta Paediatr; 2006 Mar; 95(3):312-7. PubMed ID: 16497642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrant progranulin, YKL-40, cathepsin D and cathepsin S in Gaucher disease.
    Afinogenova Y; Ruan J; Yang R; Kleytman N; Pastores G; Lischuk A; Mistry PK
    Mol Genet Metab; 2019; 128(1-2):62-67. PubMed ID: 31358474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enzymatic analysis of biomarkers for the monitoring of Gaucher patients in Colombia.
    Pacheco N; Uribe A
    Gene; 2013 May; 521(1):129-35. PubMed ID: 23523857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated plasma glucosylsphingosine in Gaucher disease: relation to phenotype, storage cell markers, and therapeutic response.
    Dekker N; van Dussen L; Hollak CE; Overkleeft H; Scheij S; Ghauharali K; van Breemen MJ; Ferraz MJ; Groener JE; Maas M; Wijburg FA; Speijer D; Tylki-Szymanska A; Mistry PK; Boot RG; Aerts JM
    Blood; 2011 Oct; 118(16):e118-27. PubMed ID: 21868580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated plasma chemokine CCL18/PARC in beta-thalassemia.
    Dimitriou E; Verhoek M; Altun S; Karabatsos F; Moraitou M; Youssef J; Boot R; Sarafidou J; Karagiorga M; Aerts H; Michelakakis H
    Blood Cells Mol Dis; 2005; 35(3):328-31. PubMed ID: 16137900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma chitotriosidase and CCL18: early biochemical surrogate markers in type B Niemann-Pick disease.
    Brinkman J; Wijburg FA; Hollak CE; Groener JE; Verhoek M; Scheij S; Aten J; Boot RG; Aerts JM
    J Inherit Metab Dis; 2005; 28(1):13-20. PubMed ID: 15702402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of velaglucerase alfa enzyme replacement therapy on red blood cell properties in Gaucher disease.
    Franco M; Reihani N; Marin M; De Person M; Billette de Villemeur T; Rose C; Colin Y; Moussa F; Belmatoug N; Le Van Kim C
    Am J Hematol; 2017 Sep; 92(9):E561-E563. PubMed ID: 28621801
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.